These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 30229466)
1. Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution. Fujita N; Koie T; Hashimoto Y; Narita T; Tobisawa Y; Tanaka T; Noro D; Oikawa M; Hagiwara K; Yoneyama T; Imai A; Yamamoto H; Hatakeyama S; Yoneyama T; Ohyama C Int Urol Nephrol; 2018 Nov; 50(11):1999-2005. PubMed ID: 30229466 [TBL] [Abstract][Full Text] [Related]
2. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients. Sugino F; Nakane K; Kawase M; Ueda S; Tomioka M; Takeuchi Y; Yamada T; Namiki S; Kumada N; Kawase K; Kato D; Takai M; Iinuma K; Tobisawa Y; Ito T; Koie T J Robot Surg; 2023 Oct; 17(5):2441-2449. PubMed ID: 37466903 [TBL] [Abstract][Full Text] [Related]
3. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins. Shapiro EY; Scarberry K; Patel T; Bergman A; Ahn JJ; Sahi N; RoyChoudhury A; Deutch I; McKiernan JM; Benson MC; Badani KK J Endourol; 2014 Feb; 28(2):208-13. PubMed ID: 24044423 [TBL] [Abstract][Full Text] [Related]
4. Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution. Fujita N; Koie T; Ohyama C; Tanaka Y; Soma O; Matsumoto T; Yamamoto H; Imai A; Tobisawa Y; Yoneyama T; Hatakeyama S; Hashimoto Y Int J Clin Oncol; 2017 Dec; 22(6):1087-1093. PubMed ID: 28681153 [TBL] [Abstract][Full Text] [Related]
5. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes. Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215 [TBL] [Abstract][Full Text] [Related]
6. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry. Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954 [TBL] [Abstract][Full Text] [Related]
7. Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer. Silberstein JL; Poon SA; Sjoberg DD; Maschino AC; Vickers AJ; Bernie A; Konety BR; Kelly WK; Eastham JA BJU Int; 2015 Jul; 116(1):50-6. PubMed ID: 24552276 [TBL] [Abstract][Full Text] [Related]